Drapeau France                     Drapeau espagne                    Drapeau UK                  drapeau américain              drapeau émirats 
Obesity  Diabetes  Erection Ejaculation Prostate Prostate adenoma Prostate atrophy Prostate cancer Immunity Hair loss
Arteriosclerosis Hypertension Coronary disease Anemia Heart infarct Muscular weakness Osteoporosis Arthrosis Depression Parkinson Alzheimer
 
Home white on blue 32x32 SITE MAP       GEORGES DEBLED MD. TV - VIDEO BOOKS
ANTI AGING SOLUTIONS FOR MAN
 


Cardiovascular risk factors

How to understand your disease of aging : ageless man

Any treatment that would be used (in case it is justified) to  decrease secretion of male hormones (testosterone and dihydrotestosterone)  should be preceded by a  check-up of the metabolic cardiovascular risk factors and  a check-up of that risks after the prescribed treatment suppressing the secretion of male hormones.

TABLE 3. Comparison of metabolic cardiovascular risk factors and plasma insulin between the low and normal PTT groups in 1992-1993

The Telecom Study) pdf.

Low PTT (n. = 25)

Normal PTT (n = 25)

P

Fasting plasma glucose (mmol/L)

5.0 ± 0.1

4.8 ± 0.1

<0.04

2-h plasma glucose (mmol/L)

5.8 ± 0.4

4.7 ± 0.2

<0.02

Triglycerides (mmol/L)

1.45 (1.23-1.72)

0.93 (0.79-1.09)

<0.001

Total cholesterol (mmol/L)

5.87 ± 0.17

5.24 ± 0.24

<0.04

HDL cholesterol (mmol/L)

1.21 ± 0.06

1.46 ± 0.07

<0.01

LDL cholesterol (mmol/L)

4.34 ± 0.16

3.58 ± 0.23

<0.01

Apo Al lipoprotein (mmol/L)

1.50 ± 0.06

1.67 ± 0.06

<0.05

Apo B lipoprotein (mmol/L)

1.40 ± 0.04

1.19 ± 0.06

<0.01

Fasting plasma insulin (pmol/L)

68.6 (57.1-82.6)

40.3 (34.8-46.6)

<0.0001

2-h plasma insulin (pmol/L)

413.8 (314.6-544.1)

147.1 (110.2-196.3)

<0.0001

 

 
 

History of andropause disease
Life maintenance system

A foundation of life maintenance system

Health in XXIst century
Andropause disease in short  (powerpoint) logo powerpoint